# Baldachin: Ceiling HEPA-filtration to Prevent Nosocomial Transmission of COVID-19

> **NCT05648097** · NA · UNKNOWN · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 104 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DEVICE:** Baldachin

## Key facts

- **NCT ID:** NCT05648097
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-13
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2023-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05648097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05648097, "Baldachin: Ceiling HEPA-filtration to Prevent Nosocomial Transmission of COVID-19". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05648097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*